MetLife Inc. Files 8-K on Financial Obligations

TL;DR

MetLife filed an 8-K on March 1st detailing new financial obligations and other corporate events.

AI Summary

On March 1, 2024, MetLife Inc. filed an 8-K report detailing events related to its financial obligations and other corporate matters. The filing includes information on the creation of direct financial obligations and obligations under off-balance sheet arrangements, as well as other events and financial statements.

Why It Matters

This filing provides insight into MetLife's financial commitments and potential liabilities, which can impact its financial health and investor confidence.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of financial obligations and corporate events, not indicating any immediate or significant new risks.

Key Players & Entities

• METLIFE INC (company) — Registrant
• March 1, 2024 (date) — Date of earliest event reported
• 200 Park Avenue, New York, New York 10166-0188 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.01 M — ich registered Common Stock, par value $0.01 MET New York Stock Exchange Floating

Filing Documents

• d792289d8k.htm (8-K) — 44KB
• d792289dex11.htm (EX-1.1) — 269KB
• d792289dex12.htm (EX-1.2) — 65KB
• d792289dex41.htm (EX-4.1) — 135KB
• d792289dex42.htm (EX-4.2) — 135KB
• d792289dex43.htm (EX-4.3) — 135KB
• d792289dex44.htm (EX-4.4) — 134KB
• d792289dex45.htm (EX-4.5) — 134KB
• d792289dex46.htm (EX-4.6) — 138KB
• d792289dex47.htm (EX-4.7) — 134KB
• d792289dex51.htm (EX-5.1) — 16KB
• g792289g01s224.jpg (GRAPHIC) — 5KB
• g792289page47.jpg (GRAPHIC) — 6KB
• 0001193125-24-062174.txt ( ) — 1828KB
• met-20240301.xsd (EX-101.SCH) — 4KB
• met-20240301_def.xml (EX-101.DEF) — 14KB
• met-20240301_lab.xml (EX-101.LAB) — 23KB
• met-20240301_pre.xml (EX-101.PRE) — 15KB
• d792289d8k_htm.xml (XML) — 8KB

Financial Statements and Exhibits

Financial Statements and Exhibits. Exhibit No. Description of Exhibit 1.1 Underwriting Agreement, dated as of March 1, 2024, among the Company and Mizuho Securities USA LLC, Morgan Stanley & Co. International plc, SMBC Nikko Securities America, Inc., and Merrill Lynch International, as representatives of the several underwriters named in Schedule I to the Pricing Agreement. 1.2 Pricing Agreement, dated March 1, 2024, among the Company and Mizuho Securities USA LLC, Morgan Stanley & Co. International plc, SMBC Nikko Securities America, Inc., and Merrill Lynch International, as representatives of the several underwriters named therein. 4.1 Thirty-Ninth Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee. 4.2 Fortieth Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee. 4.3 Forty-First Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee. 4.4 Forty-Second Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee. 4.5 Forty-Third Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee 4.6 Forty-Fourth Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee 4.7 Forty-Fifth Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee 4.8 Form of 2029 Senior Note (included as Exhibit A to Exhibit 4.1 above). 4.9 Form of 2031 Senior Note (included as Exhibit A to Exhibit 4.2 above). 4.10 Form of 2034 Senior Note (included as Exhibit A to Exhibit 4.3 above). 4.11 Form of 2039 Senior Note (included as Exhibit A to Exhibit 4.4 above). 4.12 Form of 2044 Senior Note (included as Exhibit A to Exhibit 4.5 above). 4.13 Form of 2054 Senior Note (included as Exhibit A to Exhibit 4.6 above). 4.14 Form of 2059 Senior Note (included as Exhibit A to Exhibit 4.7 above). 5.1 Opinion Letter of Willkie Far

View Full Filing

View this 8-K filing on SEC EDGAR